Viewing Study NCT05090033


Ignite Creation Date: 2025-12-25 @ 2:42 AM
Ignite Modification Date: 2026-01-08 @ 11:59 AM
Study NCT ID: NCT05090033
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-14
First Post: 2021-09-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Characterizing the Use of Ofatumumab in a Real World Setting
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module